EVerZom’s investigational drug candidate EViv, developed to treat ACLF, using its proprietary exosome platform, represents a novel approach to regenerative…
Preclinical studies demonstrated significant efficacy on systemic inflammation and organ function in ACLF disease modelsSafety data from Phase 1 on…
ALBANY, N.Y., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization,…
EAST RUTHERFORD, N.J., Aug. 25, 2025 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced…
CHESTERFIELD, Mo., Aug. 22, 2025 /PRNewswire/ -- It is with deep sadness that we announce the passing of The Rt. Hon.…
Mesquite, NV, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Dogecoin Cash, Inc. (OTCQB: DOGP), a publicly traded company focused on telehealth…
Boston, Massachusetts, June 21, 2025 (GLOBE NEWSWIRE) -- In the dynamic cryptocurrency market, XRP and DOGE have always attracted much…
Boston, Massachusetts, June 04, 2025 (GLOBE NEWSWIRE) -- XRP, the native token of the Ripple network, was designed to simplify…
Boston, Massachusetts, June 03, 2025 (GLOBE NEWSWIRE) -- With the changes of the times and the advancement of technology, people's…
Boston, Massachusetts, June 02, 2025 (GLOBE NEWSWIRE) -- SunnyMining's latest report shows that as the popularity of cryptocurrencies continues to…